share_log

凯赛生物(688065.SH):控股股东提议公司回购股份

Cathay Biotech Inc. (688065.SH): The controlling shareholder proposed the company to repurchase shares.

Gelonghui Finance ·  Oct 16, 2024 16:55

On October 16, Cathay Biotech Inc. (688065.SH) announced that the company's controlling shareholder, Cathay Industrial Biotech Ltd. (referred to as the 'controlling shareholder' or 'CIB'), issued a 'Letter on the Proposal for Cathay Biotech Inc. Shanghai to Repurchase Company Shares.' The controlling shareholder proposed that the company use its own funds to repurchase some of the RMB common shares (A shares) issued by Cathay Biotech Inc. Shanghai through the Shanghai Stock Exchange's trading system using centralized competitive bidding trading. The total amount of the repurchase funds shall not be less than RMB 10 million and not exceed RMB 20 million.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment